Cargando…
Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study
BACKGROUND: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma. However, in the authors' recent publication only a minority of patients overprescribed SABA (≥6 inhalers in 12 months) were eosinophili...
Autores principales: | Pfeffer, Paul, Hajmohammadi, Hajar, Cole, James, Griffiths, Chris, Hull, Sally, De Simoni, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354394/ https://www.ncbi.nlm.nih.gov/pubmed/36921995 http://dx.doi.org/10.3399/BJGPO.2023.0020 |
Ejemplares similares
-
Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London
por: De Simoni, Anna, et al.
Publicado: (2022) -
SABAs as Reliever Medications in Asthma Management: Evidence-Based Science
por: Amirav, Israel, et al.
Publicado: (2023) -
Missing PPI prescriptions while overprescribing?
por: Schubert, Ingrid, et al.
Publicado: (2023) -
Are clinicians overdiagnosing strep throat and overprescribing antibiotics?
por: Sabharwal, Kennedy A., et al.
Publicado: (2023) -
Hyper Vitaminosis D: Are we Overprescribing Vitamin D?
por: Hemachandar, R, et al.
Publicado: (2014)